US8992918B2 - Reactivation of axon growth and recovery in chronic spinal cord injury -
Google Patents US8992918B2 - Reactivation of axon growth and recovery in chronic spinal …

Disclosed are immunogenic Nogo receptor-1 polypeptides, Nogo receptor-1 antibodies,
antigen-binding fragments thereof, soluble Nogo receptors and fusion proteins thereof and …

Disclosed are NgR proteins and biologically active Nogo (ligand) protein fragments. Also
disclosed are compositions and methods for modulating the expression or activity of the …

The invention provides methods for treating diseases involving aberrant amyloid-β (Aβ)
peptide deposition, including Alzheimer's Disease, by the administration of Nogo receptor …

US PATENT DOCUMENTS 3,817,837 A 6, 1974 Rubenstein et al. 3,850,752 A 11/1974
Schuurs et al. 3,939,350 A 2f1976 Kronicket al. 3.996, 345 A 12/1976 Ullman et al …

US20080045926A1 - Treatment of Conditions Involving Dopaminergic Neuronal Degeneration
Using Nogo Receptor Antagonists - Google Patents US20080045926A1 - Treatment of …

0001 1. Field of the Invention 0002 This invention relates to neurobiology, neurology and
pharmacology. More particularly, it relates to methods of promoting oligodendrocyte Survival …

This application is the National Stage of International Application No. PCT/US2006/026634,
filed Jul. 7, 2006, which published under PCT Article 21 (2) in English, which claims the …